Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy
Courtney C. Walton, Paul Liknaitzky
Journal of Applied Sport Psychology November 10, 2020 DOI: 10.1080/10413200.2020.1848941 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Elite athletes |
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychotherapist Mental health Elite athletes |
| Citations | 6 |
| Key findings | Psychedelic-assisted psychotherapy should be investigated as a novel treatment option for addressing mental ill-health in elite athletes. |
Abstract
Despite a politically vilified past, classical psychedelics, including lysergic acid diethylamide (LSD), psilocybin, and dimethyltryptamine (DMT), are experiencing a revival in scientific and clinical research. When used under the appropriate guidance and setting, these substances show promise for substantially improving well-being and reducing mental ill-health alongside an excellent safety profile. Elite athletes are known to experience mental health disorder symptomatology and psychological distress at similar, if not higher, rates to the general population. Therefore, this promising line of research may be relevant to mental health treatment within elite sport. Psychedelic treatment may reduce the incidence and experience of mental ill-health in athletes, particularly when related to a range of issues commonly seen in elite sport, including therapeutic resistance, challenges to identity and meaning through career transitions and injury, and managing interpersonal stress and conflict. As a number of psychedelic treatments are currently advancing through the drug development pathway in the US and EU, it is timely to develop an understanding of the clinical application of psychedelics within elite sport, and the legislative and sport-specific regulations that will need to be addressed if psychedelics become registered medicines. In this article, we outline the sport-specific relevance of psychedelic treatments, the role of sports psychologists and psychiatrists in delivering and managing prospective psychedelic treatment, the key ethical and regulatory issues this prospective treatment raises, as well as propose initial research questions the field could address. We argue that psychedelic-assisted psychotherapy should be investigated as a novel treatment option for addressing mental ill-health in elite athletes.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 2
Cites 41
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
and 36 more in the library